モダリスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/10/12 | 1,200 | 1,209 | 1,164 | 1,173 | -38 | -3.1% | 196,700 |
2021/10/11 | 1,237 | 1,237 | 1,191 | 1,211 | -21 | -1.7% | 180,500 |
2021/10/08 | 1,230 | 1,255 | 1,218 | 1,232 | +2 | +0.2% | 202,500 |
2021/10/07 | 1,274 | 1,280 | 1,218 | 1,230 | -37 | -2.9% | 189,600 |
2021/10/06 | 1,296 | 1,305 | 1,227 | 1,267 | +25 | +2% | 302,000 |
2021/10/05 | 1,298 | 1,300 | 1,225 | 1,242 | -71 | -5.4% | 352,700 |
2021/10/04 | 1,378 | 1,378 | 1,305 | 1,313 | -65 | -4.7% | 243,200 |
2021/10/01 | 1,359 | 1,397 | 1,350 | 1,378 | +29 | +2.1% | 166,700 |
2021/09/30 | 1,380 | 1,385 | 1,314 | 1,349 | -33 | -2.4% | 221,600 |
2021/09/29 | 1,352 | 1,401 | 1,317 | 1,382 | +20 | +1.5% | 153,300 |
2021/09/28 | 1,382 | 1,393 | 1,352 | 1,362 | -38 | -2.7% | 180,200 |
2021/09/27 | 1,413 | 1,438 | 1,388 | 1,400 | -36 | -2.5% | 157,500 |
2021/09/24 | 1,450 | 1,461 | 1,424 | 1,436 | +24 | +1.7% | 151,000 |
2021/09/22 | 1,480 | 1,510 | 1,401 | 1,412 | -69 | -4.7% | 161,200 |
2021/09/21 | 1,452 | 1,490 | 1,426 | 1,481 | -39 | -2.6% | 114,700 |
2021/09/17 | 1,491 | 1,523 | 1,460 | 1,520 | +73 | +5% | 147,700 |
2021/09/16 | 1,552 | 1,560 | 1,422 | 1,447 | -110 | -7.1% | 273,500 |
2021/09/15 | 1,580 | 1,609 | 1,549 | 1,557 | -32 | -2% | 91,600 |
2021/09/14 | 1,647 | 1,660 | 1,579 | 1,589 | -67 | -4% | 146,000 |
2021/09/13 | 1,645 | 1,667 | 1,623 | 1,656 | +8 | +0.5% | 113,500 |
2021/09/10 | 1,590 | 1,659 | 1,571 | 1,648 | +77 | +4.9% | 178,400 |
2021/09/09 | 1,598 | 1,609 | 1,553 | 1,571 | -27 | -1.7% | 176,200 |
2021/09/08 | 1,560 | 1,608 | 1,534 | 1,598 | +19 | +1.2% | 121,900 |
2021/09/07 | 1,552 | 1,583 | 1,540 | 1,579 | +47 | +3.1% | 113,100 |
2021/09/06 | 1,505 | 1,548 | 1,505 | 1,532 | +40 | +2.7% | 101,200 |
2021/09/03 | 1,481 | 1,506 | 1,454 | 1,492 | +11 | +0.7% | 156,000 |
2021/09/02 | 1,549 | 1,551 | 1,474 | 1,481 | -71 | -4.6% | 260,600 |
2021/09/01 | 1,491 | 1,580 | 1,467 | 1,552 | +77 | +5.2% | 256,100 |
2021/08/31 | 1,462 | 1,482 | 1,449 | 1,475 | +13 | +0.9% | 109,900 |
2021/08/30 | 1,457 | 1,484 | 1,434 | 1,462 | +58 | +4.1% | 179,600 |
2021/08/27 | 1,410 | 1,440 | 1,390 | 1,404 | -13 | -0.9% | 91,600 |
2021/08/26 | 1,385 | 1,429 | 1,381 | 1,417 | +32 | +2.3% | 78,300 |
2021/08/25 | 1,408 | 1,418 | 1,370 | 1,385 | -23 | -1.6% | 88,200 |
2021/08/24 | 1,384 | 1,425 | 1,364 | 1,408 | +62 | +4.6% | 228,900 |
2021/08/23 | 1,349 | 1,371 | 1,331 | 1,346 | +26 | +2% | 144,900 |
2021/08/20 | 1,323 | 1,353 | 1,312 | 1,320 | -17 | -1.3% | 101,800 |
2021/08/19 | 1,320 | 1,378 | 1,320 | 1,337 | +17 | +1.3% | 225,100 |
2021/08/18 | 1,324 | 1,359 | 1,286 | 1,320 | +19 | +1.5% | 308,300 |
2021/08/17 | 1,320 | 1,332 | 1,275 | 1,301 | -27 | -2% | 193,000 |
2021/08/16 | 1,229 | 1,337 | 1,211 | 1,328 | +115 | +9.5% | 372,200 |
2021/08/13 | 1,205 | 1,308 | 1,198 | 1,213 | +13 | +1.1% | 421,900 |
2021/08/12 | 1,210 | 1,218 | 1,133 | 1,200 | -17 | -1.4% | 309,100 |
2021/08/11 | 1,180 | 1,260 | 1,180 | 1,217 | +37 | +3.1% | 334,100 |
2021/08/10 | 1,116 | 1,192 | 1,115 | 1,180 | +66 | +5.9% | 622,500 |
2021/08/06 | 1,093 | 1,195 | 1,081 | 1,114 | -189 | -14.5% | 656,400 |
2021/08/05 | 1,377 | 1,386 | 1,298 | 1,303 | -74 | -5.4% | 235,000 |
2021/08/04 | 1,435 | 1,441 | 1,344 | 1,377 | -58 | -4% | 165,900 |
2021/08/03 | 1,409 | 1,461 | 1,409 | 1,435 | +5 | +0.3% | 65,000 |
2021/08/02 | 1,417 | 1,472 | 1,417 | 1,430 | -47 | -3.2% | 110,800 |
2021/07/30 | 1,485 | 1,485 | 1,423 | 1,477 | ±0 | ±0% | 110,400 |
751~
800
件表示中 / 1043件
類似銘柄と比較する
現在ご覧いただいている「モダリス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
モダリス | 13,200円 | - | - | 0.00% | - | 6.83倍 |
|
遺伝子治療薬の創薬ベンチャー、切断しない独自のゲノム編集技術に強み。研究開発中心は米国 |
ワカモト | 23,300円 | +3.4% | - | 1.29% | 40.45倍 | 0.67倍 |
|
「強力わかもと」で有名な一般用医薬品と医家向け眼科薬が柱。乳酸菌やアジア、医療機器育成 |
ティムス | 19,600円 | - | - | 0.00% | - | 2.66倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補品を香港拠点ジーシンに導出 |
ノイルイミューン | 16,500円 | -5.1% | - | 0.00% | - | 1.43倍 |
|
独自技術用いたCAR-T細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
日ケミファ | 150,100円 | +2.5% | - | 3.33% | 90.26倍 | 0.29倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
市場注目の銘柄
チャート関連のコラム